Skip to main content

Aggrenox as a Phosphodiesterase Inhibitor

Question #8

Aggrenox is a combo drug of ASA and dipyridamole that may be prescribed to cardiac patients. However I just read that dipyridamole is a phosphodiesterase inhibitor. Just to confirm, does this mean patients with pre-existing cardiac conditions who are on Aggrenox are contraindicated for nitroglycerin administration? What if their doctor has prescribed them both Aggrenox and nitro?

Answer:

This is a great observation and great question. Fortunately, we shouldn't have to worry about this going forward as Dr. Moran has advised us that Aggrenox is no longer available in Canada. 

Medical Directive Category

Cardiac Ischemia

Published

23 January 2025

ALSPCS Version

5.3

Views

35

Please reference the MOST RECENT ALS PCS for updates and changes to these directives.